Signaling specificity in the Akt pathway in biology and disease
- PMID: 24794538
- PMCID: PMC4062840
- DOI: 10.1016/j.jbior.2014.04.001
Signaling specificity in the Akt pathway in biology and disease
Abstract
Akt/PKB is a key master regulator of a wide range of physiological functions including metabolism, proliferation, survival, growth, angiogenesis and migration and invasion. The Akt protein kinase family comprises three highly related isoforms encoded by different genes. The initial observation that the Akt isoforms share upstream activators as well as several downstream effectors, together with the high sequence homology suggested that their functions were mostly redundant. By contrast, an increasing body of evidence has recently uncovered the concept of Akt isoform signaling specificity, supported by distinct phenotypes displayed by animal strains genetically modified for each of the three genes, as well as by the identification of isoform-specific substrates and association with discrete subcellular locations. Given that Akt is regarded as a promising therapeutic target in a number of pathologies, it is essential to dissect the relative contributions of each isoform, as well as the degree of compensation in pathophysiological function. Here we summarize our view of how Akt selectivity is achieved in the context of subcellular localization, isoform-specific substrate phosphorylation and context-dependent functions in normal and pathophysiological settings.
Keywords: Akt; Cancer; Nucleus; PI 3-Kinase; Protein kinase; Signaling.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Conflict of interest statement
None declared.
Figures
Similar articles
-
RasGAP Shields Akt from Deactivating Phosphatases in Fibroblast Growth Factor Signaling but Loses This Ability Once Cleaved by Caspase-3.J Biol Chem. 2015 Aug 7;290(32):19653-65. doi: 10.1074/jbc.M115.644633. Epub 2015 Jun 24. J Biol Chem. 2015. PMID: 26109071 Free PMC article.
-
RhoA modulates signaling through the mechanistic target of rapamycin complex 1 (mTORC1) in mammalian cells.Cell Signal. 2014 Mar;26(3):461-7. doi: 10.1016/j.cellsig.2013.11.035. Epub 2013 Dec 3. Cell Signal. 2014. PMID: 24316235 Free PMC article.
-
REDD1 enhances protein phosphatase 2A-mediated dephosphorylation of Akt to repress mTORC1 signaling.Sci Signal. 2014 Jul 22;7(335):ra68. doi: 10.1126/scisignal.2005103. Sci Signal. 2014. PMID: 25056877 Free PMC article.
-
Phosphorylation of Akt at the C-terminal tail triggers Akt activation.Cell Cycle. 2014;13(14):2162-4. doi: 10.4161/cc.29584. Epub 2014 Jun 16. Cell Cycle. 2014. PMID: 24933731 Free PMC article. Review.
-
Growing knowledge of the mTOR signaling network.Semin Cell Dev Biol. 2014 Dec;36:79-90. doi: 10.1016/j.semcdb.2014.09.011. Epub 2014 Sep 19. Semin Cell Dev Biol. 2014. PMID: 25242279 Free PMC article. Review.
Cited by
-
Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.FASEB J. 2016 Aug;30(8):2926-44. doi: 10.1096/fj.201600330RR. Epub 2016 May 10. FASEB J. 2016. PMID: 27166089 Free PMC article.
-
Targeting the phosphoinositide-3-kinase/protein kinase B pathway in airway innate immunity.World J Biol Chem. 2020 Sep 27;11(2):30-51. doi: 10.4331/wjbc.v11.i2.30. World J Biol Chem. 2020. PMID: 33024516 Free PMC article. Review.
-
Traumatic Brain Injury Induces Alterations in Cortical Glutamate Uptake without a Reduction in Glutamate Transporter-1 Protein Expression.J Neurotrauma. 2017 Jan 1;34(1):220-234. doi: 10.1089/neu.2015.4372. Epub 2016 Jul 19. J Neurotrauma. 2017. PMID: 27312729 Free PMC article.
-
A predictive algorithm to identify genes that discriminate individuals with fibromyalgia syndrome diagnosis from healthy controls.J Pain Res. 2018 Nov 21;11:2981-2990. doi: 10.2147/JPR.S169499. eCollection 2018. J Pain Res. 2018. PMID: 30538537 Free PMC article.
-
AMIGO2 attenuates innate cisplatin sensitivity by suppression of GSDME-conferred pyroptosis in non-small cell lung cancer.J Cell Mol Med. 2023 Aug;27(16):2412-2423. doi: 10.1111/jcmm.17827. Epub 2023 Jul 12. J Cell Mol Med. 2023. PMID: 37438979 Free PMC article.
References
-
- Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB, et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol. 1997;7:261–9. - PubMed
-
- Alessi DR, Pearce LR, Garcia-Martinez JM. New insights into mTOR signaling: mTORC2 and beyond. Sci Signal. 2009;2:pe27. - PubMed
-
- Andjelkovic M, Alessi DR, Meier R, Fernandez A, Lamb NJ, Frech M, et al. Role of translocation in the activation and function of protein kinase B. The Journal of biological chemistry. 1997;272:31515–24. - PubMed
-
- Arboleda MJ, Lyons JF, Kabbinavar FF, Bray MR, Snow BE, Ayala R, et al. Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer research. 2003;63:196–206. - PubMed
-
- Bae SS, Cho H, Mu J, Birnbaum MJ. Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B. The Journal of biological chemistry. 2003;278:49530–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous